Oncology 2013

Scientific Program

Friday, 10th May

15.00–15.30	New imaging techniques in advanced lung cancer M. Dziuk, PL
15.30–16.00	Extended pulmonary resections in lung cancer treatment J. Schirren, DE
16.00–16.30	Satellite Session – Takeda Breakthrough pain – diagnosis and effective therapy W. Juraszek, PL
16.30–17.00	Totally implantable venous access devices in oncology – implantation techniques and complication management U. Teichgräber, DE
17.00–17.30	Satellite Session – Polpharma Depression in cancer patients – clinical significance, diagnosis and treatment P. Brudkiewicz, PL
17.30–17.45	Coffee break
17.45–18.15	Practical guide to liver lesions diagnosis W. Lisik, PL
18.15–19.00	Diagnostics algorithms in liver lesions – which techniques in which situation? R. Pacho, PL
19.00	Closing remarks
Saturday, 11th May
	Special Session
9.00–10.00	New St.Gallen recommendations 2013 J. Jassem, PL
10.00–10.30	Practical guide to changes in St.Gallen recommendations B. Sas-Korczyńska, PL
10.30–11.15	Satellite Session – GlaxoSmithKline Renal carcinoma – therapeutic options C. Szczylik, P. Tomczak, PL
11.15–11.45	Coffee break
	Liver cancer
11.45–12.15	Secondary liver tumors – reasonable multidisciplinary algorithms A. Lukashenko, UA
12.15–12.45	Thermo and radioablation of liver tumors D. Zadrożny, PL
12.45–13.15	Radiotherapy of liver tumors M. Hoyer, DK
13.15–14.15	Lunch
	Liver and gastric cancer
14.15–14.45	Hepatocellular carcinoma – 2012 update of ESMO/ESDO and EORTC/EASL recommendations C. Verslype, BE
14.45–15.15	New management strategies in advanced gastric cancer I. Shchepotin, UA
15.15–15.45	Actualisation of the Polish anticoagulation treatment guidelines M. Wojtukiewicz, PL
15.45–16.00	Coffee break
16.00–16.30	New horizon in Polish oncology – extended access to innovative therapies K. Krzemieniecki, PL (lecture coo-financed by Roche)
	Skin cancers
16.30–17.00	Current treatment of advanced/metastatic cutaneous melanoma C. Garbe, DE
17.00–17.30	Skin lymphomas – update on diagnosis and therapy R. Willemze, NL
17.30	Closing remarks